Weighted Average Number of Shares Outstanding, Diluted of Indaptus Therapeutics, Inc. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Indaptus Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • Indaptus Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 966,124, a 189% increase year-over-year.
  • Indaptus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 966,124, a 189% increase from 2024.
  • Indaptus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 334,133, a 96% decline from 2023.
  • Indaptus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8,401,047, a 1.7% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Indaptus Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 966,124 +631,991 +189% 01 Oct 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
Q3 2025 997,038 +657,379 +194% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 574,923 +269,783 +88% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 14,102,378 +5,660,014 +67% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 334,133 -8,066,914 -96% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
Q3 2024 339,659 -8,061,388 -96% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 305,140 -8,095,907 -96% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 8,442,364 +41,317 +0.49% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 8,401,047 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 8,401,047 +142,450 +1.7% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 8,401,047 +142,450 +1.7% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 8,401,047 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q3 2022 8,258,597 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 8,258,597 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2

Indaptus Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 966,124 +631,991 +189% 01 Jan 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
2024 334,133 -8,066,914 -96% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
2023 8,401,047 +138,928 +1.7% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 8,262,119 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.